Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Inflectra Launch Prep Continues Post-Deadline, Pfizer Says

Oct 06 2016

• By Derrick Gingery

Related Content

US Supreme Court Asked To Review Timing Of Biosimilar Entry

Feb 17 2016

Biosimilar Template Revisited: Inflectra Approval Binds And Separates From Remicade

Apr 06 2016

FDA Biosimilar Policy Continues To Evolve With Approval Of Sandoz Erelzi

Aug 31 2016

Pfizer Eliminates Roadblock To Remicade Biosimilar Launch

Aug 17 2016

Biosimilar Litigation: Battles Continue Over Launch Notification, Access To FDA Info

Jul 26 2016

Amgen's Amjevita Approved As First Biosimilar To AbbVie's Humira

Sep 24 2016

Related Companies

Pfizer Inc.

Celltrion, Inc.

Johnson & Johnson

Novartis AG

Teva Pharmaceutical Industries Ltd.

Biogen, Inc.

Genentech, Inc.

AbbVie Inc.

Amgen, Inc.

Additional Topics

United States Biosimilars Launches Commercial Intellectual Property Regulation BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window